Latest Period
Q2 2026
Security Snapshot
Olema Pharmaceuticals, Inc. - COMMON STOCK (OLMA) Institutional Ownership
CUSIP: 68062P106
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
181
Shares (Excl. Options)
101,883,628
Price
$12.51
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- OLMA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 101,883,628
- Total 13F value
- $1,274,770,166
- Portfolio coverage rank
- 0%
- Share change
- +398,190
- Value change
- -$15,033,838
- Number of holders
- 181
- Shares outstanding
- 87,500,447
- SEC-reported price per share
- $12.01
- Insider filing price
- $12.01
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK is tracked under CUSIP 68062P106.
- 181 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 193 to 181 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,511,791,691 to $1,274,770,166.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 181 institutions filings for Q2 2026.
Security key
68062P106
Latest holder period
Q2 2026
13F holders
181
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
OLMA full holder history
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Olema Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68062P106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
OLMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | +10% | $143,813,985 | +$24,737,094 | 12,075,062 | +21% | FMR LLC | 30 Jun 2026 |
| Bain Capital Life Sciences Opportunities IV, L.P. | 8.2% | -18% | $111,425,979 | -$15,437,859 | 7,473,238 | -12% | Bain Capital Life Sciences Opportunities IV, L.P. | 31 Mar 2026 |
| Paradigm Biocapital Advisors LP | 10% | $37,443,949 | 7,429,355 | Paradigm BioCapital Advisors LP | 31 Dec 2024 | |||
| JANUS HENDERSON GROUP PLC | 8.2% | -2.5% | $105,987,556 | +$5,938,564 | 7,108,488 | +5.9% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| BlackRock, Inc. | 7.1% | $78,115,092 | 6,244,212 | BlackRock, Inc. | 30 Jun 2026 | |||
| Invus Global Management, LLC | 5.1% | $108,693,078 | 4,461,949 | Raymond Debbane | 16 Mar 2026 | |||
| Logos Global Management LP | 4.7% | $16,172,730 | 3,208,875 | Logos Global Management LP | 18 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.3% | $7,781,412 | 1,543,931 | Point72 Asset Management, L.P. | 31 Mar 2025 |
As of 30 Jun 2026, 181 institutional investors reported holding 101,883,628 shares of Olema Pharmaceuticals, Inc. - COMMON STOCK (OLMA). This represents 116% of the company’s total 87,500,447 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
97%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 14% | 12,143,062 | +17% | 0.01% | $151,909,702 |
| Paradigm Biocapital Advisors LP | 9.9% | 8,670,576 | +8.1% | 2% | $108,468,906 |
| Jupiter Topco LLC | 8.1% | 7,094,413 | 0% | 0.04% | $88,802,842 |
| Bain Capital Life Sciences Investors, LLC | 8.1% | 7,085,249 | -5.2% | 5.3% | $88,636,465 |
| BlackRock, Inc. | 7.7% | 6,714,691 | +19% | 0% | $84,000,783 |
| BVF INC/IL | 6.1% | 5,295,893 | 0% | 1.7% | $66,251,621 |
| Siren, L.L.C. | 5.6% | 4,856,949 | +2.1% | 1.2% | $60,760,432 |
| STATE STREET CORP | 4.9% | 4,316,058 | +9.6% | 0% | $53,993,886 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 3,341,217 | +8.4% | 0% | $41,798,625 |
| Logos Global Management LP | 3.7% | 3,208,875 | 0% | 1.7% | $40,143,026 |
| FRANKLIN RESOURCES INC | 2.7% | 2,349,586 | +93% | 0.01% | $29,393,321 |
| Cormorant Asset Management, LP | 2.5% | 2,150,000 | -45% | 1.4% | $26,896,500 |
| MORGAN STANLEY | 2.1% | 1,832,269 | +51% | 0% | $22,921,685 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,819,029 | +18% | 0% | $22,759,853 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 1,663,218 | +180% | 0% | $20,806,857 |
| GOLDMAN SACHS GROUP INC | 1.8% | 1,567,979 | +50% | 0% | $19,615,417 |
| Deep Track Capital, LP | 1.7% | 1,500,000 | 0.28% | $18,765,000 | |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 1,416,533 | +31% | 0% | $17,718,405 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.5% | 1,355,299 | 0% | 0.71% | $16,954,790 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.4% | 1,200,000 | +40% | 2% | $15,012,000 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 1,131,434 | -3.2% | 0.01% | $14,154,239 |
| Point72 Asset Management, L.P. | 1.2% | 1,070,949 | +1406% | 0.02% | $13,397,572 |
| Duquesne Family Office LLC | 1.1% | 986,827 | 0% | 0.28% | $12,345,000 |
| Defilade Capital Management, L.P. | 1.1% | 924,758 | -39% | 1.5% | $11,568,723 |
| AMERIPRISE FINANCIAL INC | 0.96% | 840,646 | +1366% | 0% | $10,516,481 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 101,883,628 | $1,274,770,166 | -$15,033,838 | $12.51 | 181 |
| 2026 Q1 | 101,411,965 | $1,511,791,691 | +$99,305,974 | $14.91 | 193 |
| 2025 Q4 | 90,695,275 | $2,267,572,776 | +$591,383,435 | $25.00 | 198 |
| 2025 Q3 | 68,238,531 | $668,036,044 | -$3,229,086 | $9.79 | 124 |
| 2025 Q2 | 70,511,948 | $300,429,144 | +$22,565,282 | $4.26 | 120 |
| 2025 Q1 | 65,888,228 | $247,927,417 | -$30,654,965 | $3.76 | 131 |
| 2024 Q4 | 71,278,859 | $415,382,388 | +$48,509,843 | $5.83 | 154 |
| 2024 Q3 | 58,658,581 | $700,332,942 | +$12,555,131 | $11.94 | 129 |
| 2024 Q2 | 57,896,539 | $626,445,097 | +$18,080,243 | $10.82 | 127 |
| 2024 Q1 | 56,110,675 | $635,162,151 | +$37,635,929 | $11.32 | 125 |
| 2023 Q4 | 51,618,204 | $717,066,039 | +$56,526,765 | $14.03 | 113 |
| 2023 Q3 | 47,322,813 | $584,436,985 | +$135,063,720 | $12.35 | 97 |
| 2023 Q2 | 36,408,086 | $328,764,561 | +$43,216,272 | $9.03 | 86 |
| 2023 Q1 | 33,447,196 | $116,103,891 | +$1,469,913 | $3.47 | 65 |
| 2022 Q4 | 33,334,567 | $81,640,055 | -$481,138 | $2.45 | 66 |
| 2022 Q3 | 33,359,693 | $92,063,140 | -$4,143,577 | $2.76 | 67 |
| 2022 Q2 | 34,202,982 | $139,234,855 | -$8,391,103 | $4.07 | 70 |
| 2022 Q1 | 36,374,849 | $155,206,361 | -$17,958,891 | $4.26 | 86 |
| 2021 Q4 | 38,428,075 | $359,510,482 | -$41,441,250 | $9.36 | 94 |
| 2021 Q3 | 36,741,334 | $1,012,524,920 | -$19,680,898 | $27.56 | 75 |
| 2021 Q2 | 37,428,321 | $1,047,268,923 | +$59,576,299 | $27.98 | 68 |
| 2021 Q1 | 35,240,926 | $1,158,274,244 | -$1,710,105 | $33.18 | 73 |
| 2020 Q4 | 35,073,865 | $1,657,230,008 | +$1,657,206,010 | $48.08 | 56 |